NeuroCytotron in the Treatment of Autism Spectrum Disorder — Stella

Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

About Browse conditions ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

NeuroCytotron in the Treatment of Autism Spectrum Disorder — Stella

Home/Autism Spectrum Disorder/

View on ClinicalTrials.gov

Recruiting

Back to Autism Spectrum Disorder trials

Not a traditional drug trial — this study doesn't follow the standard phase structure.

Trial locations(1 site)

Mexico

NeuroCytonix México, San Pedro Garza García, Nuevo León

Key details

Sponsor

Neurocytonix, Inc.

Enrollment target

~100 participants

Started

July 2024

Primary completion

March 2025

This trial's estimated completion date has passed — the record may not be fully up to date.

Age range

3 Years – 50 Years

Last updated February 2025

Interested in joining?

Tell us you're interested and we'll help connect you with the research team. We'll never share your email without your permission.

Your name

Email address

Stella acts as an intermediary. Researcher contact info is never exposed.

Follow this trial

Get notified in plain English when this trial's status changes. No account required.